In the ever-evolving cannabis industry, the year 2023 marked a transformative period for Segra International. This chapter solidified its position as a leading force through a series of exceptional accomplishments, setting the stage for a year characterized by groundbreaking initiatives and an unrelenting pursuit of excellence.
The year kicked off with the release of the highly praised 2023 Cultivar Catalogue, a testament to Segra's meticulous genetic curation. This comprehensive offering not only underscored the company's commitment to research and development but also provided cultivators worldwide with a diverse range of cultivar options. Segra's dedication to tissue culture genetics, clean starting material and diversity in its catalogues attracted attention from new global markets such as New Zealand, Israel, the Netherlands, and the United Kingdom, further bolstering its already diverse international account base.
On the domestic front, Segra International emerged as a beacon of excellence within the Canadian cannabis landscape. Recognition of the unmatched quality of Segra genetics by Canadian cultivators was not a mere coincidence but a result of rigorous cultivation methods. Each plant, cultivated through the gold standard of plant tissue culture (PTC), Meristematic PTC, underwent a thorough battery of tests. From routine screenings for cannabis pathogens to DNA fingerprinting and Hop Latent Viroid (HLVd) testing with each shipment, Segra's commitment to excellence set a high standard within the Canadian Cannabis Nursery arena.
Beyond cultivar diversity, Segra prioritized fostering meaningful partnerships. The announcement of a collaboration with Compound Genetics marked not only a milestone but a commitment to sustained innovation. The revelation of a new selection in 2024 highlighted the dynamic nature of this partnership. Segra's engagement with genetic partners such as Remo Farms, The Holding Company, and Grounded Genetics added another layer of anticipation, promising a series of releases in 2024 that would capture cultivators' attention. Acknowledging the diverse needs of its customers, Segra also formed a strategic partnership with Atlas Seeds to provide top-tier F1 and auto-flower seeds to both domestic and global markets.
The accolades continued with Segra securing its second consecutive award, winning in the category of "Best Plant Propagation/Breeding" at the prestigious Grow Up Conference & Awards event. This recognition serves as a testament to Segra's unwavering commitment to advancing PTC cultivation practices, solidifying its position as a trailblazer in the cannabis genetics landscape. Recognition also extended to Segra's tissue culture cultivar "Banjo", earning the title of “Best New Preroll of the Year” at KIND, underscoring the excellence embedded in Segra's genetic offerings.
Towards the end of 2023 and the beginning of 2024, Segra International underwent transformative developments. The acquisition of Analytical and Research & Development licenses for its Microbiology lab demonstrated strategic vision, emphasizing the commitment to maintaining industry-leading standards. Simultaneously, the expansion of facilities and an evolution in packaging underscored Segra's dedication to ensuring the secure and safe delivery of its products, reaffirming its unwavering commitment to excellence.
Positioned for a Remarkable 2024: As the curtain descended on 2023, Segra International stands tall as a leader in the cannabis nursery and genetics landscape. The anticipation surrounding 2024 has already begun, promising cultivators a variety of options and surprises. From the introduction of new cultivars and pioneering partnerships to the unveiling of innovative product formats and the exploration of untapped international markets. The cannabis journey with Segra continues to unfold, inviting you to stay tuned for what promises to be another chapter of triumph, innovation, and unrivaled excellence in the ever-evolving world of cannabis.